Wyden Highlights Trump’s Lack of Action to Lower Drug Prices as Blueprint Comment Period Ends
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement as the comment period for the Trump Administration’s drug pricing “blueprint” comes to a close. “Trump has spent nearly half of his presidency making empty promises on drug prices while Big Pharma continues to raise prices on Americans unabated,” Wyden said. “Democrats […]
Wyden Refers Questionable Ross Stock Trades to Justice Department for Investigation
WASHINGTON — Following serious concerns raised by federal ethics officials about questionable stock trades by Commerce Secretary Wilbur Ross, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today formally requested a Justice Department investigation whether the trades violated federal law. The Office of Government Ethics wrote late last week that Ross’s violations of his ethics […]
Wyden Statement on Tom Price HHS Inspector General Report
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following the release of a report by the Department of Health and Human Services (HHS) Office of the Inspector General which found that former HHS Secretary Tom Price badly misused taxpayer dollars during his tenure: “This report confirms Tom Price’s role as the […]
Wyden, Murray, Blumenthal, Warren Report Reveals Cohen Attempts to Seek Investments for Russian-Linked Columbus Nova, New Details on Cohen-Novartis Business Dealings
Washington, D.C. –Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senate Health, Education, Labor and Pensions (HELP) Committee Ranking Member Patty Murray, D-Wash., Richard Blumenthal, D-Conn., and Elizabeth Warren, D-Mass., today issued a report revealing how Michael Cohen, the president’s then-personal lawyer, was pressing Novartis’ then-CEO to take up an investment opportunity that would benefit […]
Wyden: Trump Must Prove Pfizer Price Hike Delay is More than Theatrics
Letters Come as Trump Administration “Blueprint” Falls Short of the President’s Promises and Other Companies Continue to Enact Double Digit Price Hikes Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today demanded additional details on the hastily-announced agreement between Pfizer, the president, and Department of Health and Human Services (HHS) Secretary Alex […]
Wyden Statement on Cuts to Navigator Funding That Further Sabotages Americans’ Health Care
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following an announcement by the Trump Administration that it is further slashing funding for the navigator program and pushing those who apply for navigator grants to advocate for junk plans that hurt people with pre-existing conditions: “This move amounts to federally-funded fraud: paying […]
Wyden Statement on Trump Supreme Court Nominee
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., tonight expressed grave concerns about the nomination of Judge Brett Kavanaugh, to serve on the U.S. Supreme Court: “Tonight the president begins a forced march back to the days when women’s health care choices were made by government. There can be no mistaking Trump’s […]
Wyden Statement on Court Ruling on Harmful State Medicaid Waivers
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following a decision in U.S. District court to block Kentucky’s Medicaid waiver, approved by the Trump administration, which contains policies that make it harder for Americans to get health care: “Today’s decision is good news for Americans who think health care is a […]
Wyden Statement on New Tax Form
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement regarding the Trump administration’s release of the new 1040 tax form: “The administration’s new tax form is a smokescreen designed to conceal paperwork, additional calculations and Trump’s broken promise to simplify the tax code,” Wyden said. “It won’t take long for America […]
Wyden Statement at Finance Committee Markup of ACF, Commerce, and Tax Court Nominations
We will vote on the nominations off the floor of the Senate. There are several nominees up for consideration, Ms. Elizabeth Copeland and Mr. Patrick Urda are up for positions on the U.S. Tax Court. Obviously those positions deal with fairness for taxpayers as we’ve been talking about today. Mr. Jeffrey Kessler is nominated to […]